Studies have shown that chronic pain in rodents can be delayed or alleviated by intrathecal administration of neutralizing antibodies against FKN or CX3CR1 in different types of animal models of peripheral nerve injury (Milligan et al., 2004; Clark et al., 2007; Zhuang et al., 2007). Here, CX3CL1 is linked to peripheral nerve injury.